Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 12 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 11332721

    Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  2. US 11324725

    Compositions and methods for the inhibition of pruritus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  3. US 11325965

    Single-domain VH H antibodies directed to norovirus GI.1 and GII.4 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  4. US 11318196

    Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  5. US 11306132

    HLA class II-restricted T cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  6. US 11305009

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  7. US 11306131

    T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  8. US 11299476

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  9. US 11299546

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  10. US 11299517

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  11. US 11293010

    Methods of producing modified natural killer cells and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  12. US 11285142

    Compositions and methods for identifying and treating dystonia disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  13. US 11285169

    Methods for modulating chemotherapeutic cytotoxicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  14. US 11278572

    Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  15. US 11273214

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  16. US 11268096

    Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  17. US 11266692

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  18. US 11266726

    Compositions and methods for the treatment of HER2-expressing solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  19. US 11254735

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  20. US 11254662

    2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  21. US 11253511

    Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

    THE UNITED STATES OF AMERICA, as represented by th · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  22. US 11246881

    Nanoparticle to target cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  23. US 11247971

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  24. US 11248039

    Immunoglobulin single variable domain antibody against RSV prefusion F protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.